| A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients R Zivadinov, T Uher, J Hagemeier, M Vaneckova, DP Ramasamy, ... Multiple Sclerosis Journal 22 (13), 1709-1718, 2016 | 93 | 2016 |
| Gray matter atrophy patterns in multiple sclerosis: a 10-year source-based morphometry study N Bergsland, D Horakova, MG Dwyer, T Uher, M Vaneckova, M Tyblova, ... NeuroImage: Clinical 17, 444-451, 2018 | 87 | 2018 |
| Characteristics of motor speech phenotypes in multiple sclerosis J Rusz, B Benova, H Ruzickova, M Novotny, T Tykalova, J Hlavnicka, ... Multiple sclerosis and related disorders 19, 62-69, 2018 | 79 | 2018 |
| Reliable measurements of brain atrophy in individual patients with multiple sclerosis D Smeets, A Ribbens, DM Sima, M Cambron, D Horakova, S Jain, ... Brain and behavior 6 (9), e00518, 2016 | 77 | 2016 |
| Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis T Uher, M McComb, S Galkin, B Srpova, J Oechtering, C Barro, M Tyblova, ... Multiple Sclerosis Journal 27 (2), 220-231, 2021 | 71 | 2021 |
| Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis T Uher, M Vaneckova, L Sobisek, M Tyblova, Z Seidl, J Krasensky, ... Multiple Sclerosis Journal 23 (1), 51-61, 2017 | 62 | 2017 |
| Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome T Uher, J Blahova-Dusankova, D Horakova, N Bergsland, M Tyblova, ... Journal of neurology 261, 1735-1744, 2014 | 60 | 2014 |
| Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients K Fellows, T Uher, RW Browne, B Weinstock-Guttman, D Horakova, ... Journal of lipid research 56 (10), 2010-2018, 2015 | 57 | 2015 |
| Natalizumab, fingolimod, and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis WZ Yeh, PA Widyastuti, A Van der Walt, J Stankovich, E Havrdova, ... Neurology 96 (24), e2989-e3002, 2021 | 55 | 2021 |
| Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis B Srpova, T Uher, T Hrnciarova, C Barro, M Andelova, Z Michalak, ... Multiple Sclerosis Journal 27 (1), 52-60, 2021 | 54 | 2021 |
| MRI correlates of disability progression in patients with CIS over 48 months T Uher, D Horakova, N Bergsland, M Tyblova, DP Ramasamy, Z Seidl, ... NeuroImage: Clinical 6, 312-319, 2014 | 54 | 2014 |
| Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up? T Uher, E Havrdova, L Sobisek, J Krasensky, M Vaneckova, Z Seidl, ... Multiple Sclerosis Journal 23 (2), 242-252, 2017 | 51 | 2017 |
| Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach T Uher, M Vaneckova, MP Sormani, J Krasensky, L Sobisek, ... European journal of neurology 24 (2), 292-301, 2017 | 50 | 2017 |
| Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability … T Uher, D Horakova, M Tyblova, D Zeman, E Krasulova, K Mrazova, ... Multiple Sclerosis Journal 22 (6), 770-781, 2016 | 50 | 2016 |
| Neuropathic pain, depressive symptoms, and C-reactive protein in sciatica patients T Uher, P Bob International Journal of Neuroscience 123 (3), 204-208, 2013 | 50 | 2013 |
| Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients T Uher, K Fellows, D Horakova, R Zivadinov, M Vaneckova, L Sobisek, ... Journal of lipid research 58 (2), 403-411, 2017 | 49 | 2017 |
| Pathological cut-offs of global and regional brain volume loss in multiple sclerosis T Uher, M Vaneckova, J Krasensky, L Sobisek, M Tyblova, J Volna, ... Multiple Sclerosis Journal 25 (4), 541-553, 2019 | 38 | 2019 |
| Cognitive clinico‐radiological paradox in early stages of multiple sclerosis T Uher, J Krasensky, L Sobisek, J Blahova Dusankova, Z Seidl, ... Annals of clinical and translational neurology 5 (1), 81-91, 2018 | 38 | 2018 |
| Evolution of brain volume loss rates in early stages of multiple sclerosis T Uher, J Krasensky, C Malpas, N Bergsland, MG Dwyer, ... Neurology: Neuroimmunology & Neuroinflammation 8 (3), e979, 2021 | 32 | 2021 |
| Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β‐1a T Uher, D Horakova, T Kalincik, N Bergsland, M Tyblova, DP Ramasamy, ... European Journal of Neurology 22 (7), 1113-1123, 2015 | 32 | 2015 |
